On April 10, the U.S. Food and Drug Administration (FDA) released a strategic roadmap to phase out the requirement for animal testing in the preclinical evaluation of monoclonal antibodies (mAbs) and other drugs.

Read More

Recent Comments

No comments to show.

Recent Comments